Cargando…
Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
Advanced cutaneous squamous cell carcinoma (cSCC) encompasses unresectable and metastatic disease. Although immune checkpoint inhibition has been approved for this entity recently, a considerable proportion of cases is associated with significant morbidity and mortality. Clinical, histopathological,...
Autores principales: | Geidel, Glenn, Heidrich, Isabel, Kött, Julian, Schneider, Stefan W., Pantel, Klaus, Gebhardt, Christoffer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943023/ https://www.ncbi.nlm.nih.gov/pubmed/35322182 http://dx.doi.org/10.1038/s41698-022-00261-z |
Ejemplares similares
-
Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma
por: Ammann, Nadine L., et al.
Publicado: (2022) -
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
por: Stadler, Julia-Christina, et al.
Publicado: (2023) -
Current and Future Clinical Applications of ctDNA in Immuno-Oncology
por: Stadler, Julia-Christina, et al.
Publicado: (2022) -
Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
por: Heidrich, Isabel, et al.
Publicado: (2022) -
Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
por: Pantel, Klaus
Publicado: (2016)